HIV Tat protein requirements for transactivation and repression of transcription are separable

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 17, Issue 1, 1998, Pages 9-16

  Brown, Julie A ^a   Howcroft, T Kevin ^a   Singer, Dinah S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

HIV Tat protein; Repression; Transactivation; Transcription

Indexed keywords

CYSTEINE; LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; GENE REPRESSION; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; REPRESSOR GENE; TRANSACTIVATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MURINAE; RNA VIRUSES;

EID: 0031984457     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199801010-00002     Document Type: Article

References (39)

1. Cullen BR. Transactivation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 1986;46:973-82.
2. Sodroski J, Patarca C, Rosen C, Wong-Staal F, Haseltine WA. Location of the transactivating region on the genome of human T-cell lymphotropic virus type III. Science 1985;229:74-9.
3. Malim MH, Hauber J, Fenrick R, Cullen BR. Immunodeficiency virus rev transactivator modulates the expression of the viral regulatory genes. Nature 1988;335:181-3.
4. Flores S, Marecki J, Harper K, Bose S, Nelson S, McCord J. Tat protein of HIV-1 represses expression of manganese superoxide dismutase in HeLa cells. Proc Natl Acad Sci USA 1993;90:7632-6.
5. Pocsik E, Higuchi M, Aggarwal B. Down modulation of cell surface expression of p80 form of the tumor necrosis factor receptor by HIV-1 tat gene. Lymphokine Cytokine Res 1992;11:317-25.
6. Purvis SF, Georges D, Williams T, Lederman M. Suppression of IL-2 and IL-2 receptor expression in Jurkat cells stably expressing the HIV Tat protein. Cell Immunol 1992;144:32-42.
7. Sastry K, Raghava H, Pandita R, Tatpal K, Aggarwal B. HIV-1 tat gene induces TNF-β (lymphotoxin) in a human B lymphoblastoid cell line. J Biol Chem 1990;265:20091-3.
8. Westendorp M, Shatrov V, Schulze-Osthoff K, et al. HIV-Tat potentiates TNF-induced NF-kB activation and cytotoxicity by altering the cellular redox state. EMBO J 1995;14:554.
9. Scala G, Ruocco M, Ambrosino C, et al. The expression of the IL-6 gene is induced by the HIV-1 Tat protein. J Exp Med 1994;179: 961-71.
10. Howcroft TK, Strebel K, Martin M, Singer DS. Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 1993;260:1320-2.
11. Satz L, Singer DS. Effect of mouse interferon on the expression of a porcine major histocompatibility gene introduced into mouse L cells. J Immunol 1984;132:496-501.
12. Scheppler J, Nicholson J, Swan D, Ahmed-Ansari A, McDougal S. Down-modulation of MHC-I in a CD4+ T cell line. CEM-E5, after HIV-I infection. J Immunol 1989;143:2858-66.
13. Howcroft TK, Palmer L, Brown J, Rellahan B, Kashanchi F, Brady J, Singer DS. HIV Tat represses transcription through Sp1-like elements in the basal promoter. Immunity 1995;3:127-38.
14. Ehrlich R, Maguire J, Singer D. Identification of negative and positive regulatory elements associated with a class I major histocompatibility complex gene. Mol Cell Biol 1988;8:695-703.
15. Howcroft TK, Kirshner S, Singer DS. Measure of transient transfection efficiency using β-galactosidase protein. Analyt Biochem 1997;244:22-7.
16. Kuppuswamy M, Subramanian T, Srinivasan A, Chinnadurai G. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res 1989;17:3551-61.
17. Rice A, Carlotti F. Mutational analysis of the conserved eysteine-rich region of the human immunodeficiency virus type 1 Tat protein. J Virol 1990;64:1864-8.
18. Hart CE, Ou C, Galphin J, et al. Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. Science 1989;246:488-91.
19. Kashanchi F, Piras G, Radonovich M, et al. Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature 1994;367: 295-9.
20. Wang Z, Morris G, Rice A, Xiong W, Morris C. Wild type and transactivation defective mutants of HIV-1 Tat protein bind human 7 TATA binding protein in vitro. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:128-38.
21. Tiley L, Brown P, Cullen BR. Does the HIV Tat trans-activator contain a discrete activation domain? Virology 1990;178:560-7.
22. Barillari GR, Gendelman R, Gallo R, Ensoli B. The Tat protein of human immunodeficiency virus type 1. a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci USA 1993; 90:7941-5.
23. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987;238:491-7.
24. Musacchio A, Wilmanns M, Saraste M. Structure and function of the SH3 domain. Prog Biophys Mol Biol 1995;61:283-97.
25. Schumacher C, Knudsen BS, Ohichi T, Di Fiore P, Classman RH, Hanafusa H. The SH3 domain of Crk binds specifically to a conserved proline-rich motif in Eps15 and Eps15R. J Biol Chem 1995; 270:15341-7.
26. Willbold D, Rosin-Arbesfeld R, Sticht H, Frand R, Rosch P. Structure of the equine infectious anemia virus Tat protein. Science 1994;264:1584-7.
27. Jeang KT, Berkhout B, Dropulic B. Effects of integration and replication on transcription of the HIV-1 long terminal repeat. J Biol Chem 1993;268:24940-9.
28. Lee J-S, See RH, Galvin KM, Wang J, Shi Y. Functional interactions between YY1 and adenovirus E1A. Nucleic Acids Res 1995: 23:925-31.
29. Usheva A, Shenk T. TATA-binding protein-independent initiation: YY1, TFIIB, and RNA polymerase II direct basal transcription on supercoiled template DNA. Cell 1994;76:1115-21.
30. Sauer F, Jackle H. Dimerization and the control of transcription by Kruppel. Nature 1993;364:454-6.
31. Lee J.-S, Galvin K, Shi Y. Evidence for physical interaction between the zinc-finger transcription factors YY1 and Sp1. Proc Natl Acad Sci USA 1993;90:6145-9.
32. Jeang K-T, Chun R, Lin N, Gatignol A, Glabe CG, Fan H. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J Virol 1993;67:6224-33.
33. Berkout B, Jeang KT. Functional roles for TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency type 1 long terminal repeat. J Virol 1992;66:139-49.
34. Jones KA, Kadonaga JT, Luciw PA, Tjian R. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 1986;232:755-9.
35. Zimmermann K, Dobrovnik M, Ballaun C, Bevec D, Hauber J, Bohnlein E. Trans-activation of the HIV-1 LTR by the HIV-1 Tat and HTLV-1 Tax proteins is mediated by different cis-acting sequences. Virology 1991;182:874-8.
36. Jin Y, Mead J, Li T, Wolberger C, Vershon AK. Altered DNA recognition and bending by insertions in the α tail of the yeast a1/α2 homeodomain heterodimer. Science 1995;270:290-3.
37. Licht JD, Hanna-Rose W, Reddy J, et al. Mapping and mutagenesis of the amino-terminal transcriptional repression domain of the Drosophila Kruppel protein. Mol Cell Biol 1994;146:4057-66.
38. Zhou Y, Merkel TJ, Ebright RH. Characterization of the activating region of Escherichia coli catabolite gene activator protein (CAP) II. Role at class I and class II CAP-dependent promoters. J Mol Biol 1994;243:603-10.
39. Tansey WP, Ruppert S, Tjian R, Herr W. Multiple regions of TBP participate in the response to transcriptional activators in vivo. Genes Dev 1994;8:2756-69.